• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机磷抑制的乙酰胆碱酯酶重活化剂的构效关系。10. 羟基亚胺甲基芳基乙烯基吡啶甲碘化物。

Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 10. Hydroxyiminomethylarylethenylpyridine methiodides.

作者信息

Arena F, Manna F, Pizza C, Stein M L, Grifantini M

出版信息

J Med Chem. 1975 Nov;18(11):1147-50. doi: 10.1021/jm00245a022.

DOI:10.1021/jm00245a022
PMID:1177261
Abstract

The synthesis of styrylpyridine methiodides where a hydrogen of the pyridyl moiety was replaced by the hydroxyiminomethyl group produced highly effective inhibitors of acetylcholinesterase. As starting materials 4-methylpyridine-2-aldoxime and 2-methylpyridine-4-aldoxime methiodides were prepared which, together with 4-imidazolylethenyl-pyridine-2-aldoxime methiodide, were the only substances for which some activity as reactivators of phosphorylated electric eel cholinesterase in vitro could also be found.

摘要

将吡啶基部分的一个氢被羟基亚氨基甲基取代的苯乙烯基吡啶甲基碘化物合成得到了高效的乙酰胆碱酯酶抑制剂。制备了4-甲基吡啶-2-醛肟和2-甲基吡啶-4-醛肟甲基碘化物作为起始原料,它们与4-咪唑基乙烯基吡啶-2-醛肟甲基碘化物一起,是仅有的在体外对磷酸化电鳗胆碱酯酶具有一些作为重活化剂活性的物质。

相似文献

1
Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 10. Hydroxyiminomethylarylethenylpyridine methiodides.有机磷抑制的乙酰胆碱酯酶重活化剂的构效关系。10. 羟基亚胺甲基芳基乙烯基吡啶甲碘化物。
J Med Chem. 1975 Nov;18(11):1147-50. doi: 10.1021/jm00245a022.
2
Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 9. N-Heterocyclic acraldoximes methiodides.有机磷抑制的乙酰胆碱酯酶重活化剂的构效关系。9. N-杂环丙烯醛肟甲基碘化物。
J Med Chem. 1975 Aug;18(8):839-42. doi: 10.1021/jm00242a017.
3
Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity.
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3076-80. doi: 10.1016/j.bmcl.2005.04.026.
4
Quaternary salts of 3,3'-bis-pyridinium monooximes: synthesis and biological activity.3,3'-双吡啶单肟季铵盐:合成与生物活性
J Pharm Sci. 1993 Mar;82(3):258-61. doi: 10.1002/jps.2600820308.
5
Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase.新型双吡啶肟作为二异丙基氟磷酸酯抑制的乙酰胆碱酯酶复活剂的合成与评价
Eur J Med Chem. 2009 Mar;44(3):1335-40. doi: 10.1016/j.ejmech.2008.02.029. Epub 2008 Mar 7.
6
[Structure-activity relationship in reactivators of acetylcholinesterase inhibited by phosphoric esters. XII. Hydroxyiminomethylalkylpyridine iodomethylate].
Farmaco Sci. 1978 May;33(5):324-31.
7
Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 7. 1-Aryl-2-hydroxyiminomethyl-3-methylimidazolium iodides.有机磷抑制的乙酰胆碱酯酶复活剂的构效关系。7. 1-芳基-2-羟基亚氨基甲基-3-甲基咪唑碘化物。
J Med Chem. 1974 Jan;17(1):18-22. doi: 10.1021/jm00247a005.
8
Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 6. 2-Hydroxyiminomethylimidazolium iodides.
J Med Chem. 1973 Aug;16(8):937-9. doi: 10.1021/jm00266a015.
9
Synthesis and in vitro kinetic study of novel mono-pyridinium oximes as reactivators of organophosphorus (OP) inhibited human acetylcholinesterase (hAChE).新型单吡啶𬭩肟类化合物的合成及其对有机磷(OP)抑制的人乙酰胆碱酯酶(hAChE)的体外动力学研究。
Chem Biol Interact. 2015 Jul 25;237:125-32. doi: 10.1016/j.cbi.2015.06.007. Epub 2015 Jun 10.
10
New series of monoquaternary pyridinium oximes: Synthesis and reactivation potency for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase.新型单季铵吡啶肟系列:对氧磷抑制的电鳗和重组人乙酰胆碱酯酶的合成及复活效力
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5101-4. doi: 10.1016/j.bmcl.2009.07.035. Epub 2009 Jul 10.

引用本文的文献

1
Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited Cholinesterases.卤代解磷定在有机磷酸酯抑制胆碱酯酶复活中的合成与评价
ACS Med Chem Lett. 2024 Dec 2;15(12):2181-2189. doi: 10.1021/acsmedchemlett.4c00464. eCollection 2024 Dec 12.